Promarker™ is a ground-breaking platform technology that takes advantage of the ubiquity of proteins in the human body. Proteins are responsible for carrying out various functions in the body, with many diseases causing different proteins to be secreted into the blood, in varying concentrations.
The Promarker™ platform uses mass spectrometry-based technology to identify the proteins that can be used as biological markers of disease and other conditions.
The Promarker™ platform was used to discover, verify and analytically validate the panel of protein biomarkers for diabetic kidney disease. This technology platform continues to be used in the company’s certified laboratories.